Tokyo Tape
Sign in
← Japan Tobacco

Quarterly report · Q1

2914.TEDINET S100QONM
Period2023-01-01 → 2023-03-31
Filed2023-05-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥2.66T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥581.5bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥178.4bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥593.5bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥174.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥442.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥444.2bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥124.6bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥6.35Tat 2023-03-31Cons.Assets IFRS
Total assets¥6.55Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.75Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.76Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥2.93Tat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.98Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥2.89Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.54Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥655.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥721.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥483.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.0bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥101.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥22.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥306.2bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥116.8bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥249.452022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥69.942022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥249.362022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥69.912022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.1%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-03-31¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-03-31¥611m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥0
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥318m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2022-01-01 → 2022-03-31¥524.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2022-01-01 → 2022-03-31¥523.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥59m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥181.3bn
—segment totalrevenue2022-01-01 → 2022-03-31¥581.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥580.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥59m
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥186.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 843
ItemContextValueUnit
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-4892000000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-5560000000JPY
Payments for purchase of treasury shares fin cf IFRSPrior1YTDDuration-0JPY
Payments for purchase of treasury shares fin cf IFRSCurrentYTDDuration-0JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-0JPY
Other fin cf IFRSPrior1YTDDuration0JPY
Other fin cf IFRSCurrentYTDDuration0JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-116767000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-196398000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSPrior1YTDDuration-100510000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSCurrentYTDDuration-182442000000JPY
Cash and cash equivalents IFRSPrior2YearInstant721731000000JPY
Cash and cash equivalents IFRSPrior1YearInstant866885000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration34039000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-19291000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant655260000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant665152000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember523936000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember21294000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35664000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember580893000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember611000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration581505000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember59000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember0JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember59000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1226000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-1284000000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember523994000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember21294000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35664000000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember580952000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1837000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-1284000000JPY
Revenue IFRSPrior1YTDDuration581505000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember197343000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember4567000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember412000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember202322000000JPY
Segment profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-7403000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-38000000JPY
Segment profit loss IFRSPrior1YTDDuration194881000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember604331000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember24925000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35579000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember664835000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass